Inocras, a bioinformatics-led company harnessing the power of whole genome data and proprietary analytics to deliver curated insights, today announced that Accent Therapeutics will deploy Inocras’ ...
Inocras, a bioinformatics-led company harnessing the power of whole genome data and proprietary analytics to deliver curated insights, today announced that Accent Therapeutics will deploy Inocras' ...
Fulgent Genetics' diagnostics business is growing, with 15.4% revenue growth YTD and all segments contributing. Read why I ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果